PharmaSGP

PharmaSGP SE is a German pharmaceutical company publicly traded on the Frankfurt Stock Exchange under the ticker symbol PSG.DE. The company's core business is the development, marketing, and sale of branded over-the-counter (OTC) medicines and consumer healthcare products. Its operations are primarily concentrated in its home market of Germany, where it manages a portfolio of established brands. The company's product strategy is focused on two main therapeutic areas: pain management and dermatology. Within these categories, PharmaSGP offers a range of non-prescription products designed for self-medication. The company's activities encompass the entire product lifecycle, from development and regulatory approval to commercialization and supply chain management. As a publicly listed entity, PharmaSGP has undergone a funding round, reflecting its transition to the capital markets. The company operates within the broader biotech and consumer healthcare sectors, leveraging a business model centered on OTC brands with demonstrated market presence. Further information regarding its corporate structure and financial performance is available through its investor relations materials on its official website.